Strategic Shift

FingerMotion Inc. Reports Q1 FY2026 Results with Growth in Emerging Segments Amid Challenges

FingerMotion Inc. Reports Q1 FY2026 Results with Growth in Emerging Segments Amid Challenges

FingerMotion Inc. (NASDAQ: FNGR) showcases growth in new revenue segments despite a decline in its core business and increased costs, signaling a strategic shift towards data-driven growth.

July 17, 2025
Bionoid Pharma Rebrands as AI Maverick Intel, Doubles Down on AI-Driven Solutions

Bionoid Pharma Rebrands as AI Maverick Intel, Doubles Down on AI-Driven Solutions

Bionoid Pharma has transformed into AI Maverick Intel, signaling a strategic shift toward artificial intelligence-powered customer engagement technologies with potential applications across multiple industries.

May 16, 2025